Association of Diabetes Care and Education Specialists
Protects against external environmental factors with naturally occurring Vitamin A, Vitamin C, Vitamin E, and Vitamin B3
Results from new clinical trials indicate that the groundbreaking obesity and diabetes medication tirzepatide also improved symptoms of obstructive sleep apnea (OSA) Tirzepatide, sold under the brand names Mounjaro and Zepbound, is part of the class of GLP-1 drugs, similar to Ozempic, that work by mimicking a hormone in the body that slows down digestion and causes feelings of satiety, resulting significant weight loss
Bull Exp Biol Med 2019;168:1414
This can lead to several effects that promote weight loss: Increased Insulin Release: GLP-1 helps the body release more insulin, which lowers blood sugar levels and signals to the body to store excess glucose as energy instead of fat